health.kr

What It Is

health.kr is the official homepage of the Korea Pharmaceutical Information Center. Its own content describes it as “대한민국 의약품정보의 표준,” meaning a standard source for pharmaceutical information in South Korea. It provides drug search, pill identification, ingredient information, drug interaction checks, DUR, academic information, and more. Overall, it is closer to a professional pharmaceutical information database/query portal than a typical enterprise collaboration SaaS product.

Core Features and Product Capabilities

Based on the captured text, the core modules include 의약품 search, 낱알 식별 (drug appearance/pill identification), 성분정보 (ingredient information), 약물 상호작용 (drug interactions), DUR, and 학술정보 (academic information). These features are practically useful for pharmacists, medical institutions, and pharmaceutical professionals, especially for medication checks, ingredient verification, and preliminary interaction risk screening in the context of Korean drugs.

Pricing, Trial, and Deployment

The available text does not disclose plans, pricing, payment methods, a free version, or trial information, so its business model cannot be determined. What can currently be confirmed is that it is an official online service, but there is no information about self-hosting, private deployment, enterprise editions, or cloud subscriptions.

Integrations, Collaboration, and Security

The captured text does not mention third-party system integrations, APIs, developer documentation, team permissions, audit features, compliance, or data security. If an organization wants to embed it into an HIS, pharmacy system, or internal knowledge base, it would need to further verify whether interface authorization or data partnership options are available.

Pros, Cons, and Who It’s For

Its strengths are its professional focus, coverage of key pharmacy scenarios such as drug search, identification, interactions, and DUR, as well as its official status. The drawbacks are that its SaaS business capabilities cannot be confirmed from public text, and both the language and data scope are clearly oriented toward the Korean market. It is suitable for Korean pharmacists, hospital pharmacy departments, pharmaceutical professionals, researchers, and individual users who need to look up information on Korean drugs.

Access from China and Alternatives

Access from mainland China is unknown and requires actual connectivity testing; payment methods are also not disclosed. For Chinese users, the Korean-language interface and the fact that the Korean drug database does not fully correspond to drugs approved in China should also be considered. Comparable alternatives include Micromedex, UpToDate Lexidrug, Medscape Drug Interaction Checker, as well as Chinese options such as 药智数据 and 丁香园用药助手.